Goldman Sachs’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681K | Sell |
170,211
-198,107
| -54% | -$792K | ﹤0.01% | 4083 |
|
|
2025
Q1 | $1.17M | Sell |
368,318
-216,228
| -37% | -$688K | ﹤0.01% | 3701 |
|
|
2024
Q4 | $3.13M | Buy |
584,546
+208,425
| +55% | +$1.12M | ﹤0.01% | 3200 |
|
|
2024
Q3 | $1.99M | Buy |
+376,121
| New | +$1.99M | ﹤0.01% | 3377 |
|
|
2023
Q4 | – | Sell |
-49,324
| Closed | -$72K | – | 4791 |
|
|
2023
Q3 | $72K | Sell |
49,324
-44,987
| -48% | -$65.7K | ﹤0.01% | 4441 |
|
|
2023
Q2 | $216K | Buy |
+94,311
| New | +$216K | ﹤0.01% | 4366 |
|
|
2022
Q4 | – | Sell |
-17,261
| Closed | -$14K | – | 5181 |
|
|
2022
Q3 | $14K | Sell |
17,261
-22,589
| -57% | -$18.3K | ﹤0.01% | 5229 |
|
|
2022
Q2 | $39K | Sell |
39,850
-30,745
| -44% | -$30.1K | ﹤0.01% | 5327 |
|
|
2022
Q1 | $116K | Sell |
70,595
-35,210
| -33% | -$57.9K | ﹤0.01% | 5265 |
|
|
2021
Q4 | $255K | Buy |
105,805
+80,847
| +324% | +$195K | ﹤0.01% | 4856 |
|
|
2021
Q3 | $121K | Sell |
24,958
-625
| -2% | -$3.03K | ﹤0.01% | 5021 |
|
|
2021
Q2 | $68K | Sell |
25,583
-5,221
| -17% | -$13.9K | ﹤0.01% | 5206 |
|
|
2021
Q1 | $95K | Sell |
30,804
-50,950
| -62% | -$157K | ﹤0.01% | 5049 |
|
|
2020
Q4 | $291K | Sell |
81,754
-21,804
| -21% | -$77.6K | ﹤0.01% | 4097 |
|
|
2020
Q3 | $415K | Sell |
103,558
-10,722
| -9% | -$43K | ﹤0.01% | 3754 |
|
|
2020
Q2 | $311K | Buy |
114,280
+2,215
| +2% | +$6.03K | ﹤0.01% | 3810 |
|
|
2020
Q1 | $236K | Buy |
112,065
+4,889
| +5% | +$10.3K | ﹤0.01% | 3869 |
|
|
2019
Q4 | $583K | Buy |
107,176
+47,293
| +79% | +$257K | ﹤0.01% | 3572 |
|
|
2019
Q3 | $180K | Sell |
59,883
-949
| -2% | -$2.85K | ﹤0.01% | 3937 |
|
|
2019
Q2 | $228K | Buy |
60,832
+33,729
| +124% | +$126K | ﹤0.01% | 3823 |
|
|
2019
Q1 | $109K | Sell |
27,103
-12,254
| -31% | -$49.3K | ﹤0.01% | 4002 |
|
|
2018
Q4 | $144K | Buy |
39,357
+344
| +0.9% | +$1.26K | ﹤0.01% | 3822 |
|
|
2018
Q3 | $335K | Sell |
39,013
-38,962
| -50% | -$335K | ﹤0.01% | 3624 |
|
|
2018
Q2 | $856K | Buy |
77,975
+42,770
| +121% | +$470K | ﹤0.01% | 3272 |
|
|
2018
Q1 | $406K | Buy |
35,205
+10,810
| +44% | +$125K | ﹤0.01% | 3576 |
|
|
2017
Q4 | $253K | Buy |
+24,395
| New | +$253K | ﹤0.01% | 3725 |
|
|
2017
Q1 | – | Sell |
-12,110
| Closed | -$173K | – | 4419 |
|
|
2016
Q4 | $173K | Sell |
12,110
-12,580
| -51% | -$180K | ﹤0.01% | 3935 |
|
|
2016
Q3 | $406K | Buy |
24,690
+13,680
| +124% | +$225K | ﹤0.01% | 3548 |
|
|
2016
Q2 | $157K | Sell |
11,010
-15,633
| -59% | -$223K | ﹤0.01% | 3957 |
|
|
2016
Q1 | $386K | Buy |
+26,643
| New | +$386K | ﹤0.01% | 3378 |
|